Merck to Hold Investor Briefing at Boston Research Facility
April 28, 2014 6:30 am ET
Merck (NYSE:MRK), known as MSD outside the United States and Canada,
will hold an Investor Briefing on Tuesday, May 6, 2014 starting at 9:00
a.m. EDT at its research facility in Boston, MA. During the event,
members of Merck’s senior management will detail the company’s research
strategy, showcase candidates from the research and development pipeline
and provide a business update.
There will be a live webcast of the event available on Merck’s website
at www.merck.com.
Software needed to listen to the webcast may be obtained on the
corporate website and should be downloaded prior to the beginning of the
webcast. A replay of the webcast will be available by the end of the day
on May 6.
About Merck
Today’s Merck is a global healthcare leader working to help the world be
well. Merck is known as MSD outside the United States and Canada.
Through our prescription medicines, vaccines, biologic therapies, and
consumer care and animal health products, we work with customers and
operate in more than 140 countries to deliver innovative health
solutions. We also demonstrate our commitment to increasing access to
healthcare through far-reaching policies, programs and partnerships. For
more information, visit www.merck.com
and connect with us on Twitter,
Facebook
and YouTube.
Merck
Media:
Ian McConnell, 908-423-3046
or
Investor:
Carol Ferguson, 908-423-4465
